News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,153 Results
Type
Article (41816)
Company Profile (329)
Press Release (663008)
Section
Business (210132)
Career Advice (2075)
Deals (36575)
Drug Delivery (96)
Drug Development (82796)
Employer Resources (171)
FDA (16476)
Job Trends (15357)
News (355397)
Policy (33822)
Tag
Academia (2575)
Alliances (51088)
Alzheimer's disease (1247)
Approvals (16409)
Artificial intelligence (140)
Bankruptcy (362)
Best Places to Work (11668)
Biotechnology (214)
Breast cancer (122)
Cancer (1109)
Cardiovascular disease (102)
Career advice (1737)
Cell therapy (238)
Clinical research (65782)
Collaboration (395)
Compensation (202)
COVID-19 (2601)
C-suite (96)
Data (1135)
Diabetes (154)
Diagnostics (6224)
Earnings (86506)
Employer resources (149)
Events (112331)
Executive appointments (318)
FDA (17023)
Funding (357)
Gene therapy (188)
GLP-1 (610)
Government (4445)
Healthcare (18851)
Infectious disease (2686)
Inflammatory bowel disease (110)
Interviews (319)
IPO (16574)
Job creations (4051)
Job search strategy (1487)
Layoffs (433)
Legal (8320)
Lung cancer (172)
Manufacturing (185)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (20068)
Metabolic disorders (419)
Neuroscience (1531)
NextGen Class of 2024 (6625)
Non-profit (4512)
Northern California (1488)
Obesity (241)
Opinion (203)
Patents (105)
People (58231)
Pharmaceutical (92)
Phase I (20347)
Phase II (28951)
Phase III (21712)
Pipeline (460)
Postmarket research (2643)
Preclinical (8679)
Radiopharmaceuticals (241)
Rare diseases (229)
Real estate (6240)
Regulatory (22367)
Research institute (2358)
Resumes & cover letters (358)
Southern California (1308)
Startups (3712)
United States (13646)
Vaccines (567)
Weight loss (182)
Date
Today (131)
Last 7 days (712)
Last 30 days (3753)
Last 365 days (36214)
2024 (33229)
2023 (40628)
2022 (51797)
2021 (56332)
2020 (54796)
2019 (47402)
2018 (35773)
2017 (33142)
2016 (32666)
2015 (38617)
2014 (32517)
2013 (27633)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (199)
Asia (39991)
Australia (6394)
California (3350)
Canada (1299)
China (254)
Colorado (149)
Connecticut (155)
Europe (85150)
Florida (461)
Georgia (116)
Illinois (348)
Indiana (204)
Kansas (96)
Maryland (581)
Massachusetts (2651)
Michigan (158)
Minnesota (274)
New Jersey (969)
New York (965)
North Carolina (719)
Northern California (1488)
Ohio (139)
Pennsylvania (849)
South America (1157)
Southern California (1308)
Texas (472)
Washington State (368)
705,153 Results for "lotus pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
NRx Pharmaceuticals, Inc. today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical trial in bipolar depression as a material event in is February 7 financial filing.
February 9, 2024
·
3 min read
Business
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced the advance of the first $5 million milestone payment based on the Company’s partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).
February 12, 2024
·
3 min read
Business
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
Lotus Pharmaceuticals (1795:TT; “Lotus”) and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets.
June 5, 2023
·
11 min read
Press Releases
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 8, 2024
·
5 min read
Biotech Beach
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be presented at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting, being held this week in Westminster, Colorado.
June 18, 2024
·
10 min read
Business
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
Amarin Corporation plc and Lotus Pharmaceuticals announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® across 10 countries, including nine in Southeast Asia and South Korea.
July 31, 2023
·
7 min read
Genetown
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer’s Disease Treatment ADLARITY® in Multiple Markets Across Asia
Corium, LLC and Lotus Pharmaceutical announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY®, an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
August 10, 2023
·
8 min read
Pharm Country
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical stage pharmaceutical company, today announced that management will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 20, 2024
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Bexion Pharmaceuticals, Inc. to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
2 min read
1 of 70,516
Next
